Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 7 of 7 for:    mor208

Phase II MOR00208 in Combination With Lenalidomide for Patients With Relapsed or Refractory CLL, SLL or PLL or Older Patients With Untreated CLL, SLL or PLL

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02005289
Recruitment Status : Active, not recruiting
First Posted : December 9, 2013
Last Update Posted : March 26, 2019
Sponsor:
Collaborator:
MorphoSys AG
Information provided by (Responsible Party):
Jennifer Woyach, Ohio State University Comprehensive Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : October 31, 2019
  Estimated Study Completion Date : October 31, 2019